Global Custom Market Research Reports Provider Company

phone

India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Published Date: 01 Aug 2017
  • Number of Pages: 143
  • Category: Healthcare and Medical
  • Country: India
India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalDatas new report, "India Drug Delivery Devices Market Outlook to 2023", provides key market data on the India Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
- Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the India Drug Delivery Devices market.
- Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

- Develop business strategies by identifying the key market categories poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Publisher Name : GlobalData

2 Introduction 8
2.1 What Is This Report About? 8
2.2 Drug Delivery Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Drug Delivery Devices Market, India 12
3.1 Drug Delivery Devices Market, India, Revenue ($m), 2009-2023 12
3.2 Drug Delivery Devices Market, India, Revenue Mix ($m), 2016 14
3.3 Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016 15
3.4 Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16
3.5 Drug Delivery Devices Market, India, Revenue ($m), 2009-2016 17
3.6 Drug Delivery Devices Market, India, Revenue ($m), 2016-2023 19
3.7 Drug Delivery Devices Market, India, Volume (Units), 2009-2023 21
3.8 Drug Delivery Devices Market, India, Volume (Units), 2009-2016 23
3.9 Drug Delivery Devices Market, India, Volume (Units), 2016-2023 25
3.10 Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2016 27
4 Central Venous Catheters Market, India 29
4.1 Central Venous Catheters Market, India, Revenue Mix ($m), 2016 29
4.2 Central Venous Catheters Market, India, Segment Contribution (%), 2016 30
4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016 31
4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023 33
4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016 35
4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023 37
4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016 39
4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016 40
5 Infusion Systems Market, India 42
5.1 Infusion Systems Market, India, Revenue Mix ($m), 2016 42
5.2 Infusion Systems Market, India, Segment Contribution (%), 2016 43
5.3 Infusion Systems Market, India, Revenue ($m), 2009-2016 45
5.4 Infusion Systems Market, India, Revenue ($m), 2016-2023 47
5.4.1 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2009-2016 49
5.4.2 Syringe Pumps Market, India, Revenue ($m), by Segment, 2009-2016 51
5.4.3 Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2016-2023 53
5.4.4 Syringe Pumps Market, India, Revenue ($m), by Segment, 2016-2023 55
5.5 Infusion Systems Market, India, Volume (Units), 2009-2016 57
5.6 Infusion Systems Market, India, Volume (Units), 2016-2023 59
5.6.1 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2009-2016 61
5.6.2 Syringe Pumps Market, India, Volume (Units), by Segment, 2009-2016 63
5.6.3 Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2016-2023 65
5.6.4 Syringe Pumps Market, India, Volume (Units), by Segment, 2016-2023 67
5.7 Infusion Systems Market, India, Distribution Share by Revenue ($m), 2015-2016 69
5.8 Infusion Systems Market, India, Company Share by Revenue ($m), 2016 70
6 Needle Free Injections Market, India 72
6.1 Needle Free Injections Market, India, Revenue ($m), 2009-2016 72
6.2 Needle Free Injections Market, India, Revenue ($m), 2016-2023 73
6.3 Needle Free Injections Market, India, Volume (Units), 2009-2016 74
6.4 Needle Free Injections Market, India, Volume (Units), 2016-2023 75
6.5 Needle Free Injections Market, India, Distribution Share by Revenue ($m), 2015-2016 76
6.6 Needle Free Injections Market, India, Company Share by Revenue ($m), 2016 77
7 Metered Dose Inhaler Devices Market, India 79
7.1 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2009-2016 79
7.2 Metered Dose Inhaler Devices Market, India, Revenue ($m), 2016-2023 80
7.3 Metered Dose Inhaler Devices Market, India, Volume (Units), 2009-2016 81
7.4 Metered Dose Inhaler Devices Market, India, Volume (Units), 2016-2023 82
7.5 Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), 2015-2016 83
7.6 Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), 2016 84
8 Overview of Key Companies in India, Drug Delivery Devices Market 86
8.1 Teleflex Inc 86
8.1.1 Company Overview 86
8.2 GlaxoSmithKline Plc 86
8.2.1 Company Overview 86
8.3 B. Braun Melsungen AG 86
8.3.1 Company Overview 86
8.4 Baxter International Inc 86
8.4.1 Company Overview 86
8.5 AstraZeneca Plc 87
8.5.1 Company Overview 87
8.6 Boehringer Ingelheim GmbH 87
8.6.1 Company Overview 87
8.7 Fresenius Kabi AG 87
8.7.1 Company Overview 87
8.8 Pfizer Inc 87
8.8.1 Company Overview 87
8.9 Smiths Medical 88
8.9.1 Company Overview 88
8.10 Merck & Co Inc 88
8.10.1 Company Overview 88
8.11 Cipla Ltd 88
8.11.1 Company Overview 88
8.12 Hospira Inc 89
8.12.1 Company Overview 89
8.12 Terumo Corp 89
8.12.1 Company Overview 89
8.19 Becton Dickinson and Co 89
8.19.1 Company Overview 89
8.13 Medtronic Plc 89
8.13.1 Company Overview 89
8.14 Nipro Corp 90
8.14.1 Company Overview 90
9 Drug Delivery Devices Market Pipeline Products 91
10 Financial Deals Landscape 96
10.1 Acquisition 96
10.1.1 Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 96
10.2 Asset Transactions 97
10.2.1 Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 97
10.2.2 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 98
10.3 Equity Offerings 100
10.3.1 Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 100
10.4 Partnerships 101
10.4.1 Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 101
10.4.2 PharmaJet Enters into Agreement with Serum Institute of India 102
10.4.3 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 103
10.4.4 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 104
10.4.5 Eris Lifesciences Enters into Distribution Agreement with India Medtronic 106
10.4.6 Pfizer Terminates its Licensing Agreement with pSivida 107
10.4.7 Bayer Enters into Licensing Agreement with DelSiTech 108
10.4.8 BioCorRx Enters into Licensing Agreement with Therakine 109
11 Recent Developments 110
11.1 Corporate Communications 110
11.1.1 Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director 110
11.1.2 Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer 110
11.1.3 Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia 110
11.1.4 Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer 110
11.1.5 Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role 111
11.1.6 Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board 111
11.1.7 Nov 29, 2016: Cipla appoints Ireena Vittal as an Independent Director on its Board 112
11.1.8 Nov 10, 2016: Morepen Labs: Appoints Additional Director 112
11.1.9 Aug 12, 2016: Cipla Names Umang Vohra as MD & Global CEO; Samina Vaziralliis Executive Vice-Chairman 112
11.1.10 Aug 01, 2016: Cipla appoints Kedar Upadhye as Global Chief Financial Officer 113
11.2 Financial Announcements 113
11.2.1 May 26, 2017: Sun Pharma reports Q4 & FY17 results 113
11.2.2 May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets 114
11.2.3 May 12, 2017: Dr. Reddys Q4 and FY17 Financial Results 115
11.2.4 Feb 14, 2017: Sun Pharma reports Q3FY17 results 116
11.2.5 Feb 08, 2017: Morepen labs reports yet another growth-filled quarter 118
11.2.6 Feb 04, 2017: Dr. Reddys Q3 and 9M FY17 Financial Results 119
11.2.7 Nov 15, 2016: Oncocyte Announces Publication Of Breast Cancer Diagnostic Test Abstract; Poster To Be Presented At The San Antonio Breast Cancer Symposium On December 9, 2016 120
11.2.8 Nov 14, 2016: Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator 121
11.2.9 Nov 14, 2016: With Health Canada approval, Dexcom G5 Mobile CGM System is the First and Only Medical Device in North America for Making Daily Diabetes Decisions Without Painful Fingersticks 122
11.2.10 Nov 11, 2016: CHMP Adopts Positive Opinion to include Self-Administration for RUCONEST 123
11.2.11 Nov 09, 2016: Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline 124
11.2.12 Nov 09, 2016: Morepen Labs reports 118 pct jump in net profits for the Q2 of FY 2016-17 125
11.2.13 Oct 25, 2016: Dr. Reddys Q2 and H1 FY17 Financial Results 125
11.2.14 Aug 12, 2016: Sun Pharma reports Q1FY17 results 127
11.2.15 Aug 12, 2016: Sun Pharmaceutical Industries announces Unaudited results for the Quarter ended 30 th June, 2016 128
11.2.16 Aug 12, 2016: Cipla announces Q1 FY 17 Results Performance reflects continued momentum in key markets and improvement in base EBITDA margins 129
11.2.17 Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016 130
11.2.18 Jul 26, 2016: Dr. Reddys Q1 FY17 Financial Results 131
11.3 Legal And Regulatory 132
11.3.1 Jun 16, 2017: Dr. Reddys Laboratories: Update on USFDA Audit 132
11.3.2 Jun 14, 2017: Dr. Reddys Provides Update on API manufacturing plant at Miryalaguda 132
11.3.3 Jun 01, 2017: Successful AAALAC accreditation for Envigo facilities in Hyderabad, India 133
11.3.4 May 29, 2017: Phosphagenic - Mylan Arbitration Update expert report on quantum of damages claimed filed 133
11.3.5 May 25, 2017: Dr. Reddys Laboratories Provides Update on Srikakulum Plant 134
11.3.6 Apr 14, 2017: Dr. Reddys Provides Update on USFDA Audit 134
11.3.7 Apr 03, 2017: Dr. Reddys Laboratories Provides Update on USFDA Inspection at Srikakulam plant 134
11.3.8 Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility 134
11.3.9 Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility 134
11.3.10 Feb 21, 2017: Dr. Reddys Laboratories Announces US FDA Inspection on Miryalaguda Facility 135
11.3.11 Dec 13, 2016: TUV Certification for the Bengaluru Facility 135
11.3.12 Dec 08, 2016: Sun Pharma Provide Update on USFDA Inspection for Halol facility 135
11.3.13 Sep 30, 2016: Clarification sought from Cipla 135
11.4 Other Significant Developments 136
11.4.1 Feb 08, 2017: Dr. Reddys Expands Commercial Operations in Europe 136
11.4.2 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 136
11.5 Product News 136
11.5.1 May 22, 2017: Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil 136
11.6 Strategy And Business Planning 136
11.6.1 Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America 136
11.6.2 Oct 07, 2016: Leading global pharmaceutical company, Dr. Reddys Laboratories now in Colombia 137
11.6.3 Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant 137
12 Appendix 139
12.1 Research Methodology 140
12.1.1 Coverage 140
12.1.2 Secondary Research 140
12.1.3 Primary Research 141
12.1.4 Company Share Analysis 141
12.1.5 Distribution Share Analysis 141
12.1.6 Benchmarking 142
12.2 GlobalData Consulting 142
12.3 Contact Us 143
12.4 Disclaimer 143

List Of Tables


Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 13
Table 2: Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016 15
Table 3: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16
Table 4: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 18
Table 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Table 6: Drug Delivery Devices Market, India, Volume (Units), 2009-2023 22
Table 7: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016 24
Table 8: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023 26
Table 9: Drug Delivery Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016 28
Table 10: Central Venous Catheters Market, India, Segment Contribution (%), 2016 30
Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 32
Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 34
Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 36
Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 38
Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39
Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016 41
Table 17: Infusion Systems Market, India, Segment Contribution (%), 2016 44
Table 18: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 46
Table 19: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 48
Table 20: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 50
Table 21: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 52
Table 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Table 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 56
Table 24: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016 58
Table 25: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023 60
Table 26: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016 62
Table 27: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016 64
Table 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023 66
Table 29: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023 68
Table 30: Infusion Systems Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 69
Table 31: Infusion Systems Market, India, Company Share by Revenue ($m), USD Constant, 2016 71
Table 32: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 72
Table 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 73
Table 34: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016 74
Table 35: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023 75
Table 36: Needle Free Injections Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 76
Table 37: Needle Free Injections Market, India, Company Share by Revenue ($m), USD Constant, 2016 78
Table 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 79
Table 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 80
Table 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016 81
Table 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023 82
Table 42: Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 83
Table 43: Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016 85
Table 44: Drug Delivery Devices Market Pipeline Products 91
Table 45: Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs 96
Table 46: Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter 97
Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 98
Table 48: Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities 100
Table 49: Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma 101
Table 50: PharmaJet Enters into Agreement with Serum Institute of India 102
Table 51: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 103
Table 52: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 104
Table 53: Eris Lifesciences Enters into Distribution Agreement with India Medtronic 106
Table 54: Pfizer Terminates its Licensing Agreement with pSivida 107
Table 55: Bayer Enters into Licensing Agreement with DelSiTech 108
Table 56: BioCorRx Enters into Licensing Agreement with Therakine 109

List Of Figures


Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023 12
Figure 2: Drug Delivery Devices Market, India, Revenue Mix ($m), 2016 14
Figure 3: Drug Delivery Devices Market, India, Category Contribution (%), 2016 15
Figure 4: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023 16
Figure 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 17
Figure 6: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Figure 7: Drug Delivery Devices Market, India, Volume (Units), 2009-2023 21
Figure 8: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016 23
Figure 9: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023 25
Figure 10: Drug Delivery Devices Market, India, Company Share (%) 2016 27
Figure 11: Central Venous Catheters Market, India, Revenue Mix ($m), 2016 29
Figure 12: Central Venous Catheters Market, India, Segment Contribution (%), 2016 30
Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 31
Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 35
Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 37
Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016 40
Figure 18: Infusion Systems Market, India, Revenue Mix ($m), 2016 42
Figure 19: Infusion Systems Market, India, Segment Contribution (%), 2016 43
Figure 20: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 45
Figure 21: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 47
Figure 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 49
Figure 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 51
Figure 24: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Figure 25: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 55
Figure 26: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016 57
Figure 27: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023 59
Figure 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016 61
Figure 29: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016 63
Figure 30: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023 65
Figure 31: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023 67
Figure 32: Infusion Systems Market, India, Company Share (%) 2016 70
Figure 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 72
Figure 34: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 73
Figure 35: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016 74
Figure 36: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023 75
Figure 37: Needle Free Injections Market, India, Company Share (%) 2016 77
Figure 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 79
Figure 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 80
Figure 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016 81
Figure 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023 82
Figure 42: Metered Dose Inhaler Devices Market, India, Company Share (%) 2016 84

Water Pumps market in India is witnessing an impressive rate of growth on the back of of depleting ground water level, rapid urbanization, and various infrastructure initiatives launched with the

View Report

India supercapacitors market is projected to grow at a CAGR of around 16% during 2017 2022 on the account of huge demand for supercapacitors from consumer electronics segment. Supercapacitors

View Report

The report Wine Market in India to 2021 offers the most up-to-date industry data on the actual market situation, and future outlook for wines in India. The research includes historical

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports